Unichem Laboratories Limited has announced that it has received ANDA approval for its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA) to market a generic version of CELEBREX® (Celecoxib) Capsules of G.D. Searle LLC, Division of Pfizer Inc.
Celecoxib capsules are indicated for treatment of Osteoarthritis, Rheumatoid Arthritis Juvenile Rheumatoid Arthritis, Ankylosing Spondylitis, Acute Pain and Primary Dysmenorrhea. The product will be commercialized from Unichem's Goa Plant.
Shares of UNICHEM LABORATORIES LTD. was last trading in BSE at Rs.275 as compared to the previous close of Rs. 277.65. The total number of shares traded during the day was 14365 in over 790 trades.
The stock hit an intraday high of Rs. 284.5 and intraday low of 272.55. The net turnover during the day was Rs. 4007490. |
